What it is. AXPAXLI (OTX-TKI) is an investigational, bioresorbable intravitreal hydrogel implant designed to continuously ...

CEO Michael D. Dale described the second quarter as one marked by strong revenue growth and significant business milestones, stating "Q2 sales increased to $56.7 million, growing 18.3% compared to the ...

Management indicated the pivotal and ASPIRE trials are "on track to complete dosing in the second quarter of 2026." The company expects to initiate BLA-enabling process performance qualification (PPQ) ...

All dosed patients have passed one-year milestone required by U.S. Food and Drug Administration (FDA) for Accelerated Approval regulatory pathway for ST-920. According to preliminary analysis, mean ...

Owners of the popular Irish pub chain McGettigan’s, Vision Hospitality, has agreed to acquire Bla Bla Dubai, the popular ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...